Abstract
Many agents that interact with DNA have scored important clinical successes against cancer over the years. Although, there is considerable excitement today about new anticancer strategies, such as antiangiogenesis therapy, agents that target DNA are still worth pursuing, delegates were told at the 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy [ Amsterdam, The Netherlands; June 1998 ].
Rights and permissions
About this article
Cite this article
Carlson, R. Don’t forget DNA as a chemotherapy target. Inpharma Wkly. 1153, 9–10 (1998). https://doi.org/10.2165/00128413-199811530-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811530-00015